Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Paul Vigano sold 1,500,000 shares of the firm’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider directly owned 362,746 shares of the company’s stock, valued at $3,264,714. The trade was a 80.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Stock Performance
Aveanna Healthcare stock opened at $9.81 on Wednesday. The stock has a fifty day moving average of $8.60 and a two-hundred day moving average of $6.24. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of 122.63 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The company had revenue of $450.53 million during the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%. On average, analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on AVAH shares. Wall Street Zen upgraded Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. Truist Financial decreased their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. UBS Group raised their price objective on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Monday, October 13th. Weiss Ratings restated a “hold (c)” rating on shares of Aveanna Healthcare in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their price objective for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Three investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Aveanna Healthcare presently has a consensus rating of “Hold” and a consensus target price of $9.29.
Get Our Latest Research Report on Aveanna Healthcare
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also
- Five stocks we like better than Aveanna Healthcare
- The Role Economic Reports Play in a Successful Investment Strategy
- The Drone Arms Race: From Battlefield to Balance Sheet
- Dividend Payout Ratio Calculator
- Why Wall Street Is Backing These 3 Comeback Stocks
- Want to Profit on the Downtrend? Downtrends, Explained.
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
